Robin Carhart-Harris explains why his trial of psilocybin therapy vs. the SSRI escitalopram for depression missed one primary measure but favored psilocybin on almost everything else, and why SSRIs can blunt emotion.
TOPICS DISCUSSED:
• ...
Subscribe to Mind & Matter’s news feed.
Click on “Follow” and decide if you want to get news from Mind & Matter via RSS, as email newsletter, via mobile or on your personal news page.
Subscription to Mind & Matter comes without risk as you can unsubscribe instantly at any time.
You can also filter the feed to your needs via topics and keywords so that you only receive the news from Mind & Matter which you are really interested in. Click on the blue “Filter” button below to get started.
Website title: Oops! The page you were looking for doesn't exist (404)
Is this your feed? Claim it!
Robin Carhart-Harris explains why his trial of psilocybin therapy vs. the SSRI escitalopram for depression missed one primary measure but favored psilocybin on almost everything else, and why SSRIs can blunt emotion.
TOPICS DISCUSSED:
• ...
Nick talks with Prof. Gary Lewin (Max Delbrück Center, Berlin) about naked mole-rats, which in lab tests survived 18 minutes in pure nitrogen by shutting down brain activity, keeping the heart beating, and switching to fructose for fuel.
TO...
Nick talks with Prof. Lutz Schomburg about selenium biology in the endocrine system: selenoprotein P as the liver’s selenium transport protein and status biomarker, autoantibodies that can impair delivery despite normal blood selenium, thyroid autoi...